Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...

Michael David Garrison, Executive Vice President and President of Medical (TASE:PMCN) at Becton Dickinson & Co. (NYSE:BDX), recently sold 597 shares of the company’s common stock. The shares were sold ...

Becton Dickinson's (NYSE:BDX) stock is up by 4.3% over the past month. As most would know, long-term fundamentals ...

This was the stock's second consecutive day of losses.

Momentum Score Momentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook ... Based in Franklin Lakes, NJ, Becton, Dickinson and Company, ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...

Becton Dickinson & Co. closed $12.62 below its 52-week high ($248.42), which the company achieved on March 28th.

EVP Shana Carol Neal sold 788 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.17% of ...